Background: Longitudinal changes in calculated cardiovascular risk estimates vary among individuals with type 2 diabetes. We investigated whether baseline clinical data predict a relative decrease of at least 10% in a DIAL2-derived calibrated one-year risk estimate (P1Y) over approximately two years. Methods: This retrospective single-centre prediction analysis included 324 patients with valid paired scores from 332 retained clinical records. The primary elastic net model excluded treatment-group indicators; random forest was a comparator. We used three repetitions of nested stratified five-fold validation, conditional patient bootstrap intervals, and a separate bootstrap repeating model development. Additional analyses examined simpler predictor sets, continuous changes and age-fixed estimates. Results: The criterion was met by 135/324 patients (41.7%). Mean test-fold area under the receiver operating characteristic curve (AUROC) was 0.783 for elastic net and 0.784 for random forest; average precision was 0.754 and 0.744, and Brier score 0.183 and 0.187. Averaged held-out elastic net predictions had AUROC 0.786 (conditional 95% interval 0.738–0.834) and calibration slope 0.990. A four-variable benchmark had mean AUROC 0.770, and a DIAL2-component benchmark 0.792. At fixed baseline age, 230/324 (71.0%) met the criterion; the separately tuned model had mean AUROC 0.739. Median individual score change was −0.10 percentage points. Conclusions: Baseline data discriminated subsequent calculated-score trajectories in internal validation. Most predictive information was contained in baseline score constituents, and classification was sensitive to age. The analysis does not establish clinical event reduction, causal drug effects or readiness for clinical use; independent validation and assessment of decision utility are required.